U.S. Markets open in 6 hrs, 51 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,384.21 | 152.25 | 1.36% |
| NASDAQ | 2,294.44 | 51.12 | 2.28% |
| S&P 500 | 1,273.70 | 21.39 | 1.71% |
| Day Low 10:49 AM EDT | 1.43 | |
|---|---|---|
| Day High 12:40 PM EDT | 1.517 |
|
| Range | 0.09 | |
| Volume | 26,120 | |
| 30-Day Avg. Vol. | 31,000 |
|
| Difference | -15.74% | |
| Market Cap. | 51.7 M | |
| Change | 702,113 | |
| Shares Out. | 34.93 M | |
| Percent Traded | 0.07% | |
| Revenue | 9.01 M | |
| Earnings | -41.79 M | |
| EPS (TTM) | -1.45 |
| 52-Wk Low 6/20/08 | 1.40 | |
|---|---|---|
| 52-Wk High 7/16/07 | 7.15 |
|
| Range | 5.75 | |
| Prev. Close 7/7/08 | 1.46 | |
| Today's Open | 1.50 | |
| Change | 2.74% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.6377 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
Metabasis Therapeutics knows the pathways in the liver aren't lined with roses. The development-stage biotechnology company is developing small molecule drugs to combat cancer and metabolic and other diseases ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.396 12/31/07 | -0.35 12/31/07 |
0.046
Beat
|
| Last Quarter | -0.368 3/31/08 | -0.36 3/31/08 |
0.008
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 942,000.00 | 9.02 M |
| Gross Profit | -4.94 M | -31.90 M |
| Operating Income | -11.32 M | -44.34 M |
| Net Income | -11.10 M | -41.80 M |
